Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

SGMAX vs LSVFX overlap: 55% of top holdings shared

Bottom line

How much do SGMAX and LSVFX overlap?

55% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 12.5% of SGMAX's assets and 21.1% of LSVFX's. They share a meaningful core but differ in the rest of the portfolio.

SGMAX holds far more positions (602 vs 145), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

SGMAXLSVFX
Weight overlap (top 25)55%
Shared holdings14
Weight in shared holdings12.5%21.1%
Total positions602145
Expense ratio0.72%0.75%
Holdings as ofMay 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Holdings SGMAX and LSVFX have in common

Holding% of SGMAX% of LSVFXOverlap
Cisco Systems, Inc.1.67%3.02%1.67%
Verizon Communications Inc.1.10%1.26%1.10%
Pfizer Inc.0.95%0.99%0.95%
Hsbc Holdings Plc0.93%1.37%0.93%
Arrow Electronics, Inc.0.89%1.55%0.89%
At&t Inc.0.89%1.02%0.89%
Bristol-myers Squibb Company0.88%1.99%0.88%
Avnet, Inc.0.83%1.04%0.83%
Comcast Corporation0.79%1.01%0.79%
Cisco Systems, Inc.0.77%3.02%0.77%
Td Synnex Corporation0.72%1.38%0.72%
Johnson & Johnson0.69%1.15%0.69%
Novartis AG0.68%1.26%0.68%
Totalenergies Se0.66%1.03%0.66%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in SGMAX

  1. Merck & Co., Inc. — 0.78%
  2. Apple Inc. — 0.77%
  3. Telefonaktiebolaget LM Ericsson — 0.72%
  4. Incyte Corporation — 0.70%
  5. Alphabet Inc. — 0.67%
  6. Endesa, Sociedad Anonima — 0.67%
  7. Nvidia Corporation — 0.66%
  8. Eni S.p.a. — 0.64%
  9. The New York Times Company — 0.64%
  10. Te Connectivity Public Limited Company — 0.63%
  11. Cardinal Health, Inc. — 0.63%

Only in LSVFX

  1. Jazz Pharmaceuticals Public Limited Company — 1.81%
  2. The Bank of New York Mellon Corporation — 1.40%
  3. Hp Inc. — 1.27%
  4. Exxonmobil Holdings Corporation — 1.25%
  5. Altria Group, Inc. — 1.23%
  6. Krung Thai Bank Public Company Limited — 1.22%
  7. NewMarket Corporation — 1.07%
  8. Borgwarner Inc. — 1.03%
  9. Dropbox, Inc. — 1.02%
  10. Old Republic International Corporation — 1.01%
  11. UNIQA Insurance Group AG — 0.99%
  12. Magyar Telekom Tavkozlesi Nyilvanosan Mukodo Reszvenytarsasag — 0.99%

Asset mix

Asset typeSGMAXLSVFX
Stocks97.7%98.2%
Repurchase agreements—0.6%
Equity derivatives0.6%—
Preferred stock0.4%—
Cash & short-term funds0.3%—

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Country mix

CountrySGMAXLSVFX
US57.7%54.9%
JP7.3%6.9%
CA5.4%2.2%
GB3.8%5.3%
HK2.4%3.6%
FR2.2%3.4%
CH2.9%2.0%
SE2.7%1.7%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do SGMAX and LSVFX overlap?
About 55% by weight. 14 securities appear in both funds' top 25 holdings; they make up 12.5% of SGMAX's assets and 21.1% of LSVFX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do SGMAX and LSVFX have in common?
The largest shared holdings are Cisco Systems, Inc., Verizon Communications Inc., Pfizer Inc., Hsbc Holdings Plc, Arrow Electronics, Inc..
Should I own both SGMAX and LSVFX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, SGMAX or LSVFX?
SGMAX is broader, with 602 positions versus 145 for LSVFX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.